-
-
-
-
-
-
-
Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
-
-
-
-
-
-
-
Pfizer’s LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
-
-
-
-
-
-
-
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
-
-
-
-
-
-
-
Pfizer Q2 earnings preview: Analysts eye pipeline updates, portfolio resilience
-
-
-
-
-
-
-
FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
-
-
-
-
-
-
-
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
-
-
-
-
-
-
-
FDA approves expanded HYMPAVZI use for hemophilia patients with inhibitors
-
1,234,328 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


